Cedric Carter

Contact Information
Life Sciences Centre
4467 – 2350 Health Sciences Mall, Vancouver, BC V6T 1Z3
Tel 1-604-822-7275
cjcarter@interchange.ubc.ca

Current Positions

  • Associate Professor, Pathology & Laboratory Medicine, Medicine

Research Interests

  • The development and demonstration of clinical efficacy of low molecular weight heparin fractions
  • Investigation of a new antithrombin-III variant with discrepant functional to immuno ATIII levels
  • Development of laboratory markers to detect hypercoagulable states
  • Diagnostic application of platelet activation dependent antibodies

Publications

  1. Vanden Hoek AL, Talbot K, Carter IS, Vickars L, Carter CJ, Jackson SC, Macgillivray RT, Pryzdial EL. Coagulation factor X Arg386 specifically affects activation by the intrinsic pathway: a novel patient mutation. J Thromb Haemost. 2012 Dec;10(12):2613-5.
  2. Talbot K, Song J, Hewitt J, Serrano K, Ho M, Carter CJ, Macgillivray RT, Pryzdial EL. A novel compensating mechanism for homozygous coagulation factor V deficiency suggested by enhanced activated partial thromboplastin time after reconstitution with normal factor V. Br J Haematol. 2010 Oct;151(2):198-200.
  3. Carter ISR, Hewitt J, Pu CH, Wu JK, Carter CJ, MacGillivray RTA. Severe protein S deficiency resulting from two novel mutations in PROS1 presenting with a relatively mild clinical phenotype. J Thromb Haemost 2008; 6:1237-1239
  4. Maurer-Spurej E, Kahr W, Carter CJ, Pittendreigh C, Cameron M, Cyr T. The value of proteomics for the diagnosis of a platelet-related bleeding disorder. Platelets. 2008 19(5):342-351
  5. Zhang JG, Carter CJ, Culibrk B, Devine DV, Levin E, Scammell K, Weiss S, Gyongyossy-Issa MI. Buffycoat platelet variables and metabolism during storage in additive solutions or plasma. Transfusion. 2008Feb 21; [Epub ahead of print]
  6. Zhang JG, Carter CJ, Devine DV, Scammell K, Weiss S, Gyongyossy-Issa MI. Comparison of a novel viscous platelet additive solution and plasma: preparation and in vitro storage parameters of buffy-coat-derived platelet concentrates. Vox Sang. 2008 Jan 4;

Education

  • FRCP(London), Internal Medicine, 1981
  • FRCP(C), Haematology, 1976
  • FRCP(C), Internal Medicine, 1976
  • Senior Research Fellow, Ontario Heart Foundation, McMaster, 1985
  • Research Fellow, Ontario Heart Foundation, McMaster, 1980
  • B.S., St. Thomas Hospital Medical School, 1969
  • M.B., University of London, 1969

Comments are closed, but trackbacks and pingbacks are open.